Nuveen’s Medline Inc MDLN Stock Holding History

Nuveen’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.3M	Sell	591,217 -954,057	-62%	-$42.1M	0.01%	985
2025 Q4	$64.9M	Buy	+1,545,274	New	+$65.3M	0.02%	534

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Nuveen's MDLN Position: Q1 2026 in Review

Nuveen reduced its Medline Inc (MDLN) stake by 62% in Q1 2026, selling an estimated $42.1M and leaving 591,217 shares worth $26.3M. The position accounts for 0.01% of the portfolio, ranked #985.

Nuveen first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $64.9M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Nuveen held 591,217 shares of Medline Inc worth $26.3M as of Q1 2026.
Nuveen sold 954,057 Medline Inc shares in Q1 2026, an estimated $42.1M.
Medline Inc made up 0.01% of Nuveen's portfolio in Q1 2026, its #985 holding.
Nuveen first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
Nuveen's Medline Inc position peaked at $64.9M in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.